Gut microbiota as a risk and protective factor in neonatal necrotizing enterocolitis: An integrative review
Early Human Development · 2025
DOI: 10.1016/j.earlhumdev.2025.106401 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Early Human Development, 2025. Verfasst von Maria Júlia Onofre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nursing student, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil. Electronic address: mariaonofre.enf@gmail.c…. Hauptthemen laut MEDLINE: Enterocolitis, Necrotizing, Gastrointestinal Microbiome. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Necrotizing enterocolitis (NEC) is characterized by inflammation of the gastrointestinal tract and intestinal necrosis, primarily affecting premature neonates. It is one of the leading causes of morbidity and mortality in this population. This article aims to analyze, based on recent scientific literature, the relationship between intestinal microbiota and the development of NEC in premature neonates, highlighting the main pathophysiological mechanisms and prevention strategies. We conducted an integrative literature review, with search in the Virtual Health Library (VHL) and Pubmed databases, applying the Patient, Intervention, Comparison and Outcomes (PICO) strategy. A total of 178 articles were initially identified, with the application of validated tools to assess the methodological quality of the studies. The final sample included 13 international articles. The main findings show intestinal dysbiosis, activation of immune pathways and metabolic alterations as key elements in the pathogenesis of NEC. On the other hand, the use of probiotics and enrichment of breast milk were associated with beneficial effects. In conclusion, NEC is a multifactorial disease associated with intestinal dysbiosis, with an increase in pathogenic bacteria and a reduction in beneficial bacteria such as Bifidobacterium spp. The activation of pro-inflammatory TLR4 receptors by bacterial LPS favors intestinal damage. Factors such as prematurity, use of antimicrobials, and changes in the composition of breast milk favor microbiota imbalance. Probiotics and breastfeeding are promising strategies for preventing this situation. Therefore, this article gathers pertinent information that can help in understanding the factors involved in NEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nursing student, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil. Electronic address: mariaonofre.enf@gmail.com.
- Nursing student, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil. Electronic address: cesar.cirino@ufu.br.
- Postgraduate Program in Health Sciences, Faculty of Medicine, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil. Electronic address: isadoracaixeta@ufu.br.
- Department of Microbiology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil. Electronic address: denise.roder@ufu.br.
Zitieren
APA
Onofre, M. J., Augusto Cirino Silva, C., Caixeta da Silveira Ferreira, I., & Von Dolinger de Brito Röder, D. (2025). Gut microbiota as a risk and protective factor in neonatal necrotizing enterocolitis: An integrative review. Early Human Development. https://doi.org/10.1016/j.earlhumdev.2025.106401
Vancouver
Onofre MJ, Augusto Cirino Silva C, Caixeta da Silveira Ferreira I, Von Dolinger de Brito Röder D. Gut microbiota as a risk and protective factor in neonatal necrotizing enterocolitis: An integrative review. Early Human Development. 2025. doi:10.1016/j.earlhumdev.2025.106401
BibTeX
@article{Onofre2025,
author = {Onofre, Maria Júlia and Augusto Cirino Silva, Cesar and Caixeta da Silveira Ferreira, Isadora and Von Dolinger de Brito Röder, Denise},
title = {Gut microbiota as a risk and protective factor in neonatal necrotizing enterocolitis: An integrative review},
journal = {Early Human Development},
year = {2025},
doi = {10.1016/j.earlhumdev.2025.106401}
}
EUVIMED